David M Patterson

A proposal for dose-adjustment of dabigatran etexilate in atrial fibrillation guided by thrombin time.

M. Doogue, E. Begg, Daniel F. B. Wright, 2014, British journal of clinical pharmacology.

Coagulation assays and plasma fibrinogen concentrations in real-world patients with atrial fibrillation treated with dabigatran.

M. Barclay, E. Begg, B. Jensen, 2014, British journal of clinical pharmacology.

Correlation Between Trough Plasma Dabigatran Concentrations and Estimates of Glomerular Filtration Rate Based on Creatinine and Cystatin C

R. Roberts, M. Barclay, E. Begg, 2014, Drugs in R&D.